Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- SUBJECT label "dexamethasone-based regimens" provenance.
- SUBJECT label "dexamethasone-based regimens" provenance.
- SUBJECT label "dexamethasone-based regimens" provenance.
- SUBJECT label "dexamethasone-based regimens" provenance.
- SUBJECT label "dexamethasone-based regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "etoposide + dexamethasone-based chemotherapy regimens" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "using the 8 mg dexamethasone administered orally before the procedure" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )" provenance.
- SUBJECT label "either dexamethasone or methylprednisolone" provenance.
- SUBJECT label "either dexamethasone or methylprednisolone" provenance.
- SUBJECT label "either dexamethasone or methylprednisolone" provenance.
- SUBJECT label "either dexamethasone or methylprednisolone" provenance.
- SUBJECT label "either dexamethasone or methylprednisolone" provenance.
- SUBJECT label "either dexamethasone or methylprednisolone" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "After hypoxemia ( late dexamethasone group" provenance.
- SUBJECT label "Prostaglandin E2 ( PGE2 ) , synthesized primarily by astrocytes" provenance.
- SUBJECT label "Prostaglandin E2 ( PGE2 ) , synthesized primarily by astrocytes" provenance.
- SUBJECT label "Prostaglandin E2 ( PGE2 ) , synthesized primarily by astrocytes" provenance.
- SUBJECT label "Prostaglandin E2 ( PGE2 ) , synthesized primarily by astrocytes" provenance.
- SUBJECT label "Prostaglandin E2 ( PGE2 ) , synthesized primarily by astrocytes" provenance.
- SUBJECT label "Prostaglandin E2 ( PGE2 ) , synthesized primarily by astrocytes" provenance.
- SUBJECT label "( betamethasone and dexamethasone )" provenance.
- SUBJECT label "( betamethasone and dexamethasone )" provenance.
- SUBJECT label "( betamethasone and dexamethasone )" provenance.
- SUBJECT label "( betamethasone and dexamethasone )" provenance.
- SUBJECT label "( betamethasone and dexamethasone )" provenance.
- SUBJECT label "( betamethasone and dexamethasone )" provenance.